WSCM
LLY icon

Wellington Shields Capital Management’s Eli Lilly LLY Stock Holding History

Wellington Shields Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.2M Sell
5,656
-185
-3% -$188K 0.78% 28
2025
Q4 		$6.28M Sell
5,841
-30
-0.5% -$28.7K 0.92% 26
2025
Q3 		$4.48M Buy
5,871
+687
+13% +$511K 0.68% 33
2025
Q2 		$4.04M Hold
5,184
– – 0.68% 32
2025
Q1 		$4.28M Sell
5,184
-38,776
-88% -$32.3M 0.78% 29
2024
Q4 		$4.18M Buy
43,960
+38,035
+642% +$31.5M 0.74% 29
2024
Q3 		$5.25M Buy
5,925
+238
+4% +$214K 0.91% 22
2024
Q2 		$5.15M Sell
5,687
-381
-6% -$305K 0.94% 21
2024
Q1 		$4.72M Sell
6,068
-566
-9% -$403K 0.89% 25
2023
Q4 		$3.87M Buy
6,634
+390
+6% +$228K 0.48% 27
2023
Q3 		$3.35M Sell
6,244
-100
-2% -$51.5K 0.44% 27
2023
Q2 		$2.98M Sell
6,344
-135
-2% -$56.6K 0.36% 34
2023
Q1 		$2.23M Sell
6,479
-518
-7% -$175K 0.27% 50
2022
Q4 		$2.56M Hold
6,997
– – 0.31% 44
2022
Q3 		$2.26M Buy
6,997
+100
+1% +$31.7K 0.54% 45
2022
Q2 		$2.24M Sell
6,897
-3
-0% -$901 0.28% 51
2022
Q1 		$1.98M Sell
6,900
-365
-5% -$93.9K 0.22% 70
2021
Q4 		$2.01M Buy
7,265
+475
+7% +$120K 0.26% 84
2021
Q3 		$1.57M Sell
6,790
-475
-7% -$117K 0.21% 89
2021
Q2 		$1.67M Sell
7,265
-81
-1% -$16.3K 0.2% 100
2021
Q1 		$1.37M Buy
7,346
+100
+1% +$19.6K 0.13% 125
2020
Q4 		$1.22M Buy
7,246
+425
+6% +$63.5K 0.16% 110
2020
Q3 		$1.01M Sell
6,821
-23
-0.3% -$3.56K 0.16% 97
2020
Q2 		$1.12M Buy
6,844
+23
+0.3% +$3.53K 0.18% 98
2020
Q1 		$946K Sell
6,821
-900
-12% -$124K 0.18% 101
2019
Q4 		$1.01M Sell
7,721
-400
-5% -$46.4K 0.16% 121
2019
Q3 		$908K Sell
8,121
-100
-1% -$11.1K 0.15% 128
2019
Q2 		$911K Sell
8,221
-2,620
-24% -$309K 0.15% 121
2019
Q1 		$1.41M Sell
10,841
-3,200
-23% -$389K 0.24% 87
2018
Q4 		$1.63M Buy
14,041
+5,909
+73% +$660K 0.31% 74
2018
Q3 		$873K Hold
8,132
– – 0.14% 144
2018
Q2 		$694K Sell
8,132
-4,300
-35% -$353K 0.11% 170
2018
Q1 		$962K Hold
12,432
– – 0.15% 141
2017
Q4 		$1.05M Sell
12,432
-2,500
-17% -$213K 0.16% 127
2017
Q3 		$1.28M Sell
14,932
-2,000
-12% -$164K 0.21% 108
2017
Q2 		$1.39M Sell
16,932
-1,400
-8% -$114K 0.23% 104
2017
Q1 		$1.54M Buy
18,332
+700
+4% +$56.1K 0.25% 95
2016
Q4 		$1.3M Buy
17,632
+700
+4% +$52.1K 0.22% 105
2016
Q3 		$1.36M Hold
16,932
– – 0.24% 101
2016
Q2 		$1.33M Buy
16,932
+600
+4% +$45.2K 0.23% 90
2016
Q1 		$1.18M Buy
16,332
+600
+4% +$45.4K 0.21% 99
2015
Q4 		$1.33M Buy
15,732
+273
+2% +$22.7K 0.22% 83
2015
Q3 		$1.29M Sell
15,459
-401
-3% -$33.9K 0.22% 85
2015
Q2 		$1.32M Buy
15,860
+1,112
+8% +$84.7K 0.2% 101
2015
Q1 		$1.07M Buy
14,748
+1
+0% +$71 0.16% 121
2014
Q4 		$1.02M Buy
14,747
+14
+0.1% +$945 0.16% 129
2014
Q3 		$955K Sell
14,733
-17
-0.1% -$1.08K 0.16% 134
2014
Q2 		$917K Sell
14,750
-1
-0% -$60 0.14% 145
2014
Q1 		$868K Buy
14,751
+227
+2% +$12.7K 0.15% 141
2013
Q4 		$741K Buy
14,524
+21
+0.1% +$1.05K 0.13% 152
2013
Q3 		$730K Sell
14,503
-2,031
-12% -$106K 0.14% 144
2013
Q2 		$812K Buy
+16,534
New +$900K 0.14% 147

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Shields Capital Management's LLY Position: Q1 2026 in Review

Wellington Shields Capital Management reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $188K and leaving 5,656 shares worth $5.2M. The position accounts for 0.78% of the portfolio, ranked #28.

Wellington Shields Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.28M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wellington Shields Capital Management held 5,656 shares of Eli Lilly worth $5.2M as of Q1 2026.
  • Wellington Shields Capital Management sold 185 Eli Lilly shares in Q1 2026, an estimated $188K.
  • Eli Lilly made up 0.78% of Wellington Shields Capital Management's portfolio in Q1 2026, its #28 holding.
  • Wellington Shields Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Wellington Shields Capital Management's Eli Lilly position peaked at $6.28M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wellington Shields Capital Management's 13F filing for Q1 2026, filed 4 May 2026.